OptMed

About:

OptMed is a biotech company that develops and commercializes biocompatible polymer and genitourinary therapeutic platforms.

Website: http://optmed.net

Description:

OptMed develops and commercializes biocompatible polymer and genitourinary therapeutic platforms. Its biocompatible polymers platform serves for biosurgical adhesive and sealant, and industrial adhesive applications. The company’s and genitourinary therapeutics platform serves for the treatment of lower urinary tract conditions, including overactive bladder and kidney stones. Its products include Devakor, a topical skin adhesive for surgical sutures. OptMed was incorporated in 2007 and is based in Woodmere, New York.

Total Funding Amount:

$9.19M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)optmed.com

Founders:

Alain Klapholz

Number of Employees:

1-10

Last Funding Date:

2015-08-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai